StockStars.net Tuesday Midday Report
Jun 10th, 2009 by beststockreport
IGNT hit a high of $0.02 this morning, a gain of 809% from Sunday.
NTRO was up as much as 203% from Friday’s midday report.
HRNF is trading at all time lows and I think the stock could make a monster comeback.
HRNF is a super sub-penny and each uptick would mean huge percentage gains.
HRNF just announced it completed another distribution agreement for its Super Food brand ACAI Plus functional chewing gum.
ACAI Plus functional chewing gum is a healthy and natural choice for the delivery of super high anti-oxidants equivalent to 17,000 ORAC in two Chiclets.
This level of anti-oxidant is absorbed at the cell level and cleans out free radicals from the body which cause a multitude of conditions, including inflammation, stress, fatigue, etc.
HRNF * may get a correction
Heathrow Natural Food & Beverage, Inc. is a national distributor of the botanical Super Food beverage, Exfuze Seven + and Exfuze Seven + Pro as well as the Heathrow Super Food Brand which includes, ACAI Plus Chewing Gum, Super Food Bar and Super Food Snack Chips. HNFB is part of the $100 Billion Dollar Wellness Industry, which is growing at 10% per year. The nutritional beverage and functional supplement segment is the largest sector of the market at 27% of sales. HNFB provides healthy and natural choices for the growing segment of the population seeking a healthy and active lifestyle.
INTK * encouraging developments
Industrial Nanotech Inc. is emerging as a global nanoscience solutions and research leader and member of the U.S. Greenbuilding Council and the American Solar Energy Society. The Company develops and commercializes new and innovative applications for nanotechnology.
ARDM * staging a turnaround
Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of a portfolio of drugs delivered by inhalation for the treatment of severe respiratory diseases by pulmonologists. Current activities include partnered and self-initiated development programs addressing the treatment of cystic fibrosis, bronchiectasis, pulmonary arterial hypertension, COPD, inhalation anthrax infections and smoking cessation.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
*********************************************************
The disclaimer is to be read and fully understood before using our site or joining our email list.
PLEASE NOTE WELL: StockStars.net and/or its affiliates are not registered as Investment Advisors in any jurisdiction whatsoever.
Release of Liability: Through use of StockStars.net email newsletter and website you agree to hold StockStars.net, its operators, owners, and employees harmless and completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. The owner, publisher, editor and their associates are not responsible for errors and omissions. StockStars.net and/or its affiliates may from time to time have positions in the securities mentioned herein, may increase or decrease such positions without notice, and may profit from such transactions. StockStars.net has been compensated by another third party three thousand dollars for a HRNF news alert. StockStars.net has been compensated by a third party seventy five hundred dollars for a one day IGNT advertising services contract. StockStars.net was previously compensated by a third party five thousand dollars for NTRO advertising services. StockStars.net has been compensated by another third party three thousand dollars for a NTRO news alert. The third parties may have shares and may liquidate, which may affect the stocks’ price. Any opinions expressed are subject to change without notice. StockStars.net encourages readers and investors to supplement the information in these reports with independent research and other professional advice.
Please read our full disclaimer at http://www.stockstars.net/disclaimer.php.